» Articles » PMID: 38552632

SALL3 Mediates the Loss of Neuroectodermal Differentiation Potential in Human Embryonic Stem Cells with Chromosome 18q Loss

Overview
Publisher Cell Press
Specialty Cell Biology
Date 2024 Mar 29
PMID 38552632
Authors
Affiliations
Soon will be listed here.
Abstract

Human pluripotent stem cell (hPSC) cultures are prone to genetic drift, because cells that have acquired specific genetic abnormalities experience a selective advantage in vitro. These abnormalities are highly recurrent in hPSC lines worldwide, but their functional consequences in differentiating cells are scarcely described. In this work, we show that the loss of chromosome 18q impairs neuroectoderm commitment and that downregulation of SALL3, a gene located in the common 18q loss region, is responsible for this failed neuroectodermal differentiation. Knockdown of SALL3 in control lines impaired differentiation in a manner similar to the loss of 18q, and transgenic overexpression of SALL3 in hESCs with 18q loss rescued the differentiation capacity of the cells. Finally, we show that loss of 18q and downregulation of SALL3 leads to changes in the expression of genes involved in pathways regulating pluripotency and differentiation, suggesting that these cells are in an altered state of pluripotency.

Citing Articles

Gain of 1q confers an MDM4-driven growth advantage to undifferentiated and differentiating hESC while altering their differentiation capacity.

Krivec N, Couvreu de Deckersberg E, Lei Y, Al Delbany D, Regin M, Verhulst S Cell Death Dis. 2024; 15(11):852.

PMID: 39572522 PMC: 11582570. DOI: 10.1038/s41419-024-07236-x.


SALL2 regulates neural differentiation of mouse embryonic stem cells through Tuba1a.

Xiong H, Lin B, Liu J, Lu R, Lin Z, Hang C Cell Death Dis. 2024; 15(9):710.

PMID: 39349437 PMC: 11442768. DOI: 10.1038/s41419-024-07088-5.


De Novo Cancer Mutations Frequently Associate with Recurrent Chromosomal Abnormalities during Long-Term Human Pluripotent Stem Cell Culture.

Al Delbany D, Ghosh M, Krivec N, Huyghebaert A, Regin M, Duong M Cells. 2024; 13(16).

PMID: 39195283 PMC: 11353044. DOI: 10.3390/cells13161395.


Culture-acquired genetic variation in human pluripotent stem cells: Twenty years on.

Vales J, Barbaric I Bioessays. 2024; 46(12):e2400062.

PMID: 38873900 PMC: 11589660. DOI: 10.1002/bies.202400062.

References
1.
Price C, Stavish D, Gokhale P, Stevenson B, Sargeant S, Lacey J . Genetically variant human pluripotent stem cells selectively eliminate wild-type counterparts through YAP-mediated cell competition. Dev Cell. 2021; 56(17):2455-2470.e10. PMC: 8443275. DOI: 10.1016/j.devcel.2021.07.019. View

2.
Jo H, Lee Y, Ahn H, Han H, Kwon A, Kim B . Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation. Sci Rep. 2020; 10(1):18582. PMC: 7596514. DOI: 10.1038/s41598-020-75657-7. View

3.
Wuu Y, Pampfer S, Vanderheyden I, Lee K, de Hertogh R . Impact of tumor necrosis factor alpha on mouse embryonic stem cells. Biol Reprod. 1998; 58(6):1416-24. DOI: 10.1095/biolreprod58.6.1416. View

4.
Maitra A, Arking D, Shivapurkar N, Ikeda M, Stastny V, Kassauei K . Genomic alterations in cultured human embryonic stem cells. Nat Genet. 2005; 37(10):1099-103. DOI: 10.1038/ng1631. View

5.
Mateizel I, Spits C, De Rycke M, Liebaers I, Sermon K . Derivation, culture, and characterization of VUB hESC lines. In Vitro Cell Dev Biol Anim. 2010; 46(3-4):300-8. DOI: 10.1007/s11626-010-9284-4. View